Article Text

200 Diurnal Variation In Sympathetic Control Of Excitation-contraction Coupling: The Role Of ß3 Adrenoceptors And Nitric Oxide
  1. Glenn Rodrigo,
  2. Iain Squire,
  3. Hayley Crumbie
  1. University of Leicester


We have previously shown a time-of-day variation in the response of systolic [Ca2+]i to the non-specific ß-adrenergic (ß-ADR) agonist isoproterenol (ISO), which is linked to a variation in Nitric Oxide (NO) signalling [1]. This may reflect stimulation of ß3-ADRs, which induces a NO-dependent negative inotropic response [2]. As action potential duration (APD) impacts systolic [Ca2+]i and a time-of-day variation exists in the regulation AP [3], we investigated the effect of ß3-ADR stimulation on the APD and systolic [Ca2+]i.

Ventricular myocytes were isolated by enzymatic digestion of male Wistar rat hearts at two time points; 3 h into the rest-period and active-period. [Ca2+]i was measured in myocytes loaded with Fura-2. APD was measured using whole-cell patch-clamp recording. I to and I LTCC current density were measured using the whole-cell voltage-clamp technique. Data shown as number of hearts (number of cells), mean ± S.E.M., 2-way ANOVA, Tukey’s post hoc test.

In order to determine whether the previously shown time-of-day variation in response to ISO can be explained by a variation in ß3-ADR dependant NOS signalling, we investigated systolic [Ca2+]i in rest and active-period myocytes in response to the specific ß3-ADR agonist BRL37344. BRL37344 (200 nM) resulted in a significant reduction in systolic [Ca2+]i in rest-period myocytes, from 458.5 ± 41.2 nM to 361.2 ± 18.0 nM (n = 3–4 (18–19), P < 0.001) but had no significant effect on active period myocytes.

BRL37344 also significantly reduced APD30, 18.3 ± 2.2 ms to 14.4 ± 1.6 ms (P < 0.001), and APD50, 32.9 ± 4.3 ms to 26.5 ± 3.1 ms, (P < 0.001) in rest-period myocytes (n = 3–4 (12–15) with no significant change in either APD30/50 in active-period myocytes.

I to current density was measured in rest-period myocytes using K+ electrode solution; cell perfusate contained 200 nM CdCl2 to block Ca2+ currents. BRL37344 caused a significant drop in I to density at +30 mV, from 6.38 ± 0.90 to 4.59 ± 0.11 pA/pF (n = 4 (13), P < 0.05). There was a small but non-significant recovery of the reduction due to BRL following NOS inhibition with L-NNA.

I LTCC current density was measured in rest-period myocytes using Cs electrode solution to block K+ currents. Stimulation of ß3-ADR with BRL37344 caused no significant difference in either peak LTCC current density, from -7.46 ± -0.50 to -8.09 ± -0.80 pA/pF, or in the voltage dependence of the peak Ca2+ current, 0mV (n = 3 (13)).

The time-of-day variation we have described previously is seen a decreased [Ca2+]i sensitivity during the active-period. Therefore, our data suggests that ß3-ADR dependant NOS signalling is not likely to be responsible for this time-of-day variation as BRL37344 caused a significant drop in [Ca2+]i and APD30/50 in rest-period myocytes only. Further investigation of the effect of BRL37344 on rest-period myocytes appears to show the reduction in [Ca2+]i and APD30/50 is not due to an increase in the I to or to a reduction in I LTCC.

  • sympathetic stimulation
  • nitric oxide
  • ß3-ADR

Statistics from

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.